Introduction
Dendritic cells (DC) are specialist antigen-presenting cells blood DC) appear to represent the precursors of the tissue DC, but even a brief period of in vitro culture induces blood (reviewed in 1,2). As immature cells, DC reside in nonlymphoid organs, e.g. Langerhans cells (LC) in the skin. DC DC to acquire the phenotype of mature DC (3). Whilst it is well known that fresh blood DC present soluble antigens are most accessible in the blood, where they circulate in low numbers, but DC can also be isolated from tissues including (4-8), studies concentrating on antigen uptake by freshly isolated human blood DC are few in number and are the skin. Alternatively, DC can be generated after 5-14 days in vitro culture of bone marrow, cord blood or blood-derived complicated by the fact that isolation techniques can influence DC phenotype or function (9,10). Although antigen precursors including monocytes, using defined cytokine conditions (reviewed in 1,2). Cells obtained by these different uptake by freshly isolated blood DC has been visualized by electron microscopy (7), the cell surface molecules involved methods exhibit functional and phenotypic features of the DC lineage; however, the exact relationship between these cell are not known. In contrast, antigen uptake by LC (11-13) and monocyte-derived DC (Mo-DC) has been studied more types has yet to be clarified. Circulating blood DC (immature (14) (15) (16) (17) (18) . A better understanding of the mechanisms DC use Cytokines, antibodies and chemicals for taking up antigen may help develop better methods for rhIL-4 was obtained from Sigma (St Louis, MO), rhGM-CSF loading DC with cancer or microbial antigens for clinical was from Sandoz-Pharma (Auckland, New Zealand) and rh immunotherapy protocols.
TNF-α was from Hoffman-La Roche (Basel, Switzerland). mAb Carbohydrate-conjugated antigen uptake by DC has been used were the following: the 15-2 (IgG1, anti-MMR) (28) was studied by eliciting an immune response against pathogenic a gift from Dr C. Rijken (TNO Prevention and Health, Leiden, microorganisms such as yeasts, bacteria and parasites, as Netherlands). The Na 1/34 (IgG2a, CD1a) was a gift from Dr. well as loading artificially prepared antigens conjugated with A. McMichael (Institute of Molecular Medicine, Oxford, UK). carbohydrates (12, [14] [15] [16] [17] [18] [19] . Lectin-type receptors, especially Phycoerythrin (PE)-conjugated CD3 (Leu4, IgG1), CD14 the macrophage mannose receptor (MMR) (14, 15, 17, 19) and (LeuM3, IgG2b), CD16 (Leu11c, IgG1), CD19 (LeuM12, IgG1), DEC-205 (20) , have been implicated in the uptake of carboand HLA-DR (L243, IgG2a) with appropriate subclass hydrate-conjugated antigen by DC. Both molecules belongs controls were from Becton Dickinson (San Jose, CA). PEto a family of transmembrane C-type lectins, containing a Cy5-conjugated anti-HLA-DR (Imm-357, IgG1) and a cysteine-rich (CR) domain, fibronectin type II (FNII) domain, subclass control was from Coulter-Immunotech (Sydney, NSW, multiple C-type carbohydrate recognition-like domains (CRD; Australia). PE-CD83 (HB15a, IgG2b) was from Immunotech eight for MMR and 10 for DEC-205), a transmembrane domain (Marseille, France). CMRF-44 (IgM) was made in-house (29) . and a short cytoplasmic tail (20) (21) (22) . The MMR is found on FITC-conjugated sheep anti-mouse Ig (FITC-SAM) and FITCthe cell surface of macrophages and a subset of endothelial conjugated sheep anti-rabbit (FITC-SAR) Fab were from cells, and its CRD mediate the endocytosis of glycoconAmrad Biotech (Amrad Biotech, Boronia, VIC, Australia). Goat jugates with terminal mannose, fucose, N-acetylglucosamine anti-human MMR was a gift from Dr. P. Stahl (Washington or glucose residues and microorganisms with terminal University, St Louis, MO) (30) . Unless specified all chemicals mannose or N-acetylglucosamine on their cell surface were purchased from Sigma (Castle Hill, NSW, Australia) or (reviewed in 23). Because these terminal sugars are rarely BDH Chemicals (Palmerston North, New Zealand). found in mammalian cell surface or serum proteins, the MMR may be involved in discrimination of self from non-self Preparation of human DEC-205-Ig fusion protein antigens. The MMR was also found recently to bind sulfated A~800 bp PCR fragment containing the human DEC-205 signal glycoproteins (e.g. lutropin and thyrotropin) containing SO 4 -peptide, CR domain and FNII domain was amplified from 4GalNAcβ1,4GlcNAcβ1 via the CR domain and to be involved pBK14-1 (27) with a T3 sequencing primer (5Ј-AATin the clearance of these hormones from the blood stream TAACCCTCACTAAAGGG-3Ј) and a DEC-205 gene-specific (24) . Mouse DEC-205 was identified (20) as the antigen primer (5Ј-ACGGATCCACTTACCTGTAGGCTTTAAGCAGATrecognized by the rat mAb NLDC-145, which binds to LC GCCCCA-3Ј at nucleotide 668-698) containing a BamHI site and thymic epithelia (25, 26) in tissue sections. Human DEC-(underlined) and a splicing donor sequence (in italics) using 205 has been cloned recently (10,27), but its tissue distribution the Expand PCR system (Roche Molecular Biochemicals, and function are unclear. Despite the structural similarity Auckland, New Zealand). The fragment was digested with between the DEC-205 and MMR, the overall amino acid BamHI and EcoRI, cloned into the pIg1 vector (31) , and the similarity is only 27%, and the ligand specificity and function DNA sequence confirmed. The resultant plasmid (pCR/FNof DEC-205 is unknown. The MMR has been identified in Ig) was transfected to COS-7 cells using Fugene 6 (Roche Mo-DC as a major C-type lectin receptor mediating mannoMolecular Biochemicals) according to the manufacturer's sylated-antigen uptake (17, 18) and presentation (14, 15, 19) .
recommendation. The conditioned medium was collected 5-7 Of note, although mouse LC take up insoluble mannosylated days after transfection, and subjected to a HiTrap Protein A antigens (e.g. yeast and zymosan), it was reported that mouse column (Amersham Pharmacia Biotech, Auckland, New LC lack immunologically detectable MMR (12), suggesting Zealand) and a DEC-205 Ig fusion protein (CR/FN-Ig) purified that alternative receptors for mannosylated antigens are according to the manufacturer's recommendation. To confirm present on mouse LC. the identity, the CR/FN-Ig was subjected to N-terminus amino This study provides the first comparison of the distribution of acid sequencing by the Protein Microchemistry Facility the MMR and DEC-205 on human blood DC, LC and Mo-DC, (University of Otago, Dunedin, New Zealand). This was SGRAA, and compares this with the ability of these different DC corresponding to the predicted amino acid sequence of human populations to take up FITC-dextran.
DEC-205 at positions 28-32 (27) , confirming the identity of this fusion protein as well as the predicted signal peptide cleavage site, based on the mouse DEC-205 data (32 and data not Methods shown).
Tissue culture Preparation of rabbit anti-human DEC-205
L428 cells were provided by Dr V. Diehl (Klinik fü r Innere Two New Zealand rabbits were immunized 4 times Medizin, Cologne, Germany), and were maintained in intradermally with~50 µg of CR/FN-Ig according to the RPMI 1640, 10% FCS, 100 U/ml penicillin and 100 µg/ml conventional immunization protocol using both incomplete (for streptomycin. COS-7 cells were from ATCC (Rockville, MD) primary immunization) and complete Freund's adjuvant and cultured in Dulbecco's modified Eagle's MEM, 10% FCS, (Sigma). After checking the titer against CR/FN-Ig by ELISA, the rabbits were exanguinated to collect the sera. The sera 100 U/ml penicillin and 100 µg/ml streptomycin. HLA-DR ϩ LC were sorted by FACS or gated for antigen uptake experiments. twice, blocked with 10% mouse serum for 5 min, and then incubated with PE-conjugated second antibody for 20 min, Immature and mature Mo-DC were prepared as described previously (35) . Briefly, T lymphocyte-depleted PBMC were washed and analyzed. For staining with rabbit anti-DEC-205, cells were incubated with 1:300 diluted anti-DEC-205 IgG for plated on Falcon tissue culture plastic (Becton Dickinson Labware, Franklin Lakes, NJ) and allowed to adhere for 2 h. 30 min, washed, incubated with FITC-SAR for 20 min, washed and analyzed. The non-immune rabbit serum was used as a
The non-adherent cells were removed, and the adherent cells cultured for 7 days in RPMI 1640, 10% FCS, 50 U/ml rhIL-4 negative control. Analysis of labeled cells was performed using a FACS Vantage flow cytometer (Becton Dickinson) and 200 U/ml rhGM-CSF. The cells were labeled sequentially with CD1a, FITC-SAM and PE-CD14, and immature Mo-DC equipped with a 488 nm argon ion laser (Ion Laser Technologies, Salt Lake City, UT). The instrument was calibrated daily were sorted by FACS as CD1a ϩ CD14 -cells. For mature Mo-DC, lipopolysaccharide (LPS) (Sigma; 1 µg/ml) was added using standardized fluorescent beads (CaliBRITE; Becton Dickinson). When possible, at least 10,000 events were at day 5 to the culture described above, and the cells cultured for further 2 days. The cells were labeled subsequently with acquired from each sample and analyzed using CellQuest software (Becton Dickinson). Live cells were gated on the CD83, FITC-SAM and PE-CD14, and mature Mo-DC were sorted by FACS as CD14 -CD83 ϩ cells. basis of forward and side scatter characteristics. In some experiments propidium iodide exclusion was used to gate Macrophages were prepared from human PBMC as described previously (36) . Briefly, tissue culture plasticlive cells.
adherent cells in T lymphocyte-depleted PBMC were cultured Cell preparation for 4 days in RPMI 1640 and 10% pooled AB serum. Adherent cells were harvested in ice-cold PBS, 0.1% BSA and 5 mM Both normal human blood and normal breast skin were obtained locally with an appropriate informed consent and EDTA by pipetting. Macrophages were gated on the basis of forward and 90°light scatter characteristics by FACS. local Ethical Committee approval.
Immature and activated blood DC was prepared from RT-PCR analysis human peripheral blood as described previously (3,33). Briefly, peripheral blood mononuclear cells (PBMC) were Total RNA was isolated from FACS-purified cells (10 4 -10 5 cells/preparation, purity Ͼ95%) using the RNeasy kit (Qiagen, prepared by isolation over Ficoll-Paque gradients (Amersham Pharmacia Biotech). T lymphocytes were removed by reHilden, Germany). The RNA was treated with RNase-free DNase I (Life Technologies, Gaithersburg, MD) and reverse setting with neuraminidase-treated sheep erythrocytes, followed by Ficoll-Paque separation. Contaminating erythrotranscribed with SuperScript II (Life Technologies) with an oligo d(T) 18 primer. The resultant cDNA was subjected to cytes were removed by ammonium chloride lysis. T lymphocyte-depleted PBMC were labeled with a mixture of anti-PCR using primers specific for human DEC-205 (27) and MMR (21, 22) (Table 1) . Human GAPDH ( 37) was used for CD3, -CD14, -CD16 and -CD19. After incubation with goat anti-mouse Ig-coated magnetic beads (Miltenyi Biotech, normalization of the cDNA input. To confirm no contamination of genomic DNA in the DNase I-digested RNA, the RNA Gladbach, Germany), labeled cells were removed by magnetic immunodepletion. The resulting lineage-depleted cells preparation was subjected to PCR without reverse transcription for GAPDH which primers could utilize genomic DNA were subsequently labeled with FITC-SAM and PE-HLA-DR, and further purified by FACS. Immature blood DC were as a template if contaminated. PCR reactions were fractionated with 2% agarose gel (BioRad, Hercules, CA) and transferred to a charged nylon membrane (Micron Separations INC, Westbrough, MA) using a vacuum blotting apparatus (BioRad) and UV cross-linked (Stratagene, La Jolla, CA). The membrane was probed with the digoxigeninlabeled internal primers specific for DEC-205, MMR and GAPDH (see Table 1 ), and the specific signals were detected by chemiluminescence according to the manufacturer's recommendation (Roche Molecular Biologicals). all from Sigma) for 10 min at 37°C and then used in uptake experiments. Cells were washed 3 times with ice-cold PBS, 0.1% BSA and 0.01% NaN 3 , and labeled on ice with PEconjugated appropriate mAb. The uptake was calculated as we examined the cell surface expression of DEC-205 on the change in MFI between cell samples incubated at 37 immature and activated blood DC, immature and mature and 4°C.
Mo-DC, and macrophages by FACS analysis (Fig. 1) . LowThe uptake by immature blood DC was assessed by a level expression of DEC-205 was present on lin -HLA-DR low three-color FACS protocol developed to minimize the possible immature blood DC (Fig. 1A) . After overnight culture in changes in their phenotype and function during the purification the presence of FCS, the differentiated/activated lineageprocedure. Briefly, blood was collected and PBMC were negative blood DC formed two subsets based on HLA-DR isolated immediately by Ficoll-Paque gradient separation. The positivity. However, the DEC-205 expression on both lin -HLAcells were directly subjected to FITC-dextran and lucifer DR high (a mixture of CD11c ϩ and CD11c -) and lin -HLA-DR low yellow uptake as described above, and labeled with PE-CD3, (CD11c -) blood DC subsets was similar to that of immature PE-CD14, PE-CD16, PE-CD19 and PE-Cy5-HLA-DR or with blood DC, indicating that this differentiation/activation of blood appropriate control antibodies for 15 min on ice. Cells were DC had minimal effect on the cell surface DEC-205 expression. 
Human blood DC and LC lack immunologically detectable Results

MMR DEC-205 is expressed on blood and Mo-DC
Using the 15-2 mAb against human MMR, we examined the expression of the MMR on immature and differentiated/ We prepared the monospecific IgG anti-human DEC-205 by immunizing rabbits with the DEC-205-Ig fusion protein activated blood DC, LC, immature and matured Mo-DC, and macrophages (Fig. 2) . FACS analysis with the 15-2 did not (CR/FN-Ig) as described in the Methods. Using this antibody The effect of sugar inhibitors (galactose, mannose or mannan at 1 mg/ml) on FITC-dextran uptake. Cells with high FITCdextran uptake were preincubated with inhibitors and further incubated with FITC-dextran. The results were normalized using the uptake without inhibitor as 100% (mean Ϯ SD, n ϭ 3). detected in freshly isolated, immature blood DC, LC, immature Mo-DC and macrophages. The signal level increased markedly in differentiated/activated blood DC and in mature Mo-DC, indicating again that DEC-205 is a differentiation/activation-associated antigen. No MMR mRNA was detected in immature and differentiated/activated blood DC and LC. An apparently high level of MMR mRNA was detected in immature Mo-DC, but this decreased to undetectable levels upon their maturation. A low level of the transcript was detected in macrophages. These results confirmed that blood Genomic DNA-free total RNA was purified from FACS-purified DC and macrophages (purity Ͼ95%), reverse-transcribed with a oligo d(T) 18 DC and LC do not express the MMR, and the expression of primer, and subjected to RT-PCR and Southern blot analysis for DECboth DEC-205 and MMR is, at least in a part, transcriptionally 205 and MMR. GAPDH was used for normalization of cDNA input.
regulated.
Comparison of FITC-dextran and lucifer yellow uptake by immature blood DC with other cell types
detect any surface MMR on either immature, differentiated/ activated blood DC or LC, whereas both immature Mo-DC Cells representing various preparation of DC (immature and differentiated/activated blood DC, LC, and immature Mo-DC) and macrophages showed high levels of MMR expression as expected (17, 18) . The MMR expression diminished upon and macrophages were compared for their ability to take up FITC-dextran (Fig. 4A, left panel) . Lucifer yellow was used to maturation of Mo-DC induced by LPS. It was noted that the MMR expression on immature Mo-DC was~10-fold higher assess the level of pinocytosis that would also contribute FITC-dextran uptake (Fig. 4A, right panel) . LC, immature Mothan that of macrophages, probably due to the presence of IL-4 during culture (38) . Similar results were obtained with DC and macrophages all showed high levels of endocytoxic activity. The FITC-dextran uptake by LC, immature Mo-DC the polyclonal goat anti-MMR (data not shown), indicating that the lack of MMR staining on blood DC and LC was not and macrophages showed ∆MFI ϭ 486 Ϯ 190, 470 Ϯ 52 and 640 Ϯ 284 (n ϭ 3) (mean Ϯ SD) respectively, and the lucifer due to selectable loss or blockade of the 15-2 epitope.
yellow uptake ∆MFI ϭ 195 Ϯ 98, 164 Ϯ 82 and 116 Ϯ 49
Expression of DEC-205 and MMR mRNA in DC
(n ϭ 3) respectively. In contrast, immature blood DC showed minimal activity for both FITC-dextran uptake (∆MFI ϭ 7.3 Ϯ RT-PCR analysis was performed to assess the expression of human DEC-205 and MMR at the transcriptional level within 7.5, n ϭ 3) and lucifer yellow (∆MFI ϭ 0.3 Ϯ 0.6, n ϭ 3). The differentiated/activated blood DC were slightly more active in highly purified blood DC, LC, Mo-DC and macrophages (purity Ͼ95%) (Fig. 3) . A low level of DEC-205 mRNA was FITC-dextran uptake (∆MFI ϭ 30.3 Ϯ 10.0, n ϭ 3) than immature blood DC; however, the lucifer yellow uptake phages and a subset of vascular and lymphatic endothelial cells (45,46). Our results support the latter based on three (∆MFI ϭ 1.0 Ϯ 0.4, n ϭ 3) remained minimal, suggesting that the FITC-dextran uptake by differentiated/activated blood DC experiments: (i) mAb 15-2 and polyclonal anti-MMR fail to stain LC (Fig. 2) , (ii) RT-PCR failed to detect MMR mRNA in was mediated by receptor-dependent endocytosis, rather than pinocytosis. Both FITC-dextran and Lucifer yellow LC (Fig. 3) and (iii) FITC uptake by LC was not inhibited with mannose (Fig. 4) , a potent inhibitor of MMR-dextran binding uptake by immature and differentiated/activated blood DC was markedly less than that of either LC immature Mo-DC or (39). We noted, however, that mannan could partly inhibit the FITC-dextran uptake by LC more efficiently than mannose, macrophages.
FITC-dextran uptake by immature Mo-DC is predominantly suggesting that a mannan receptor exists on LC, even though the majority of FITC-dextran uptake appeared to be mediated mediated by MMR and the binding of MMR to FITC-dextran can be inhibited by mannose or a mannan, but not by by pinocytosis as shown by lucifer yellow uptake (Fig. 4) . Recently, Milone and Fitzgerald-Bocarsly reported that galactose (17, 18, 39) . Therefore, the inhibition study with these sugars was performed to determine the contribution the MMR present on blood DC mediated the uptake of enveloped RNA and DNA viruses and induction of IFN-α (47). of mannose-specific receptors for the FITC-dextran uptake (Fig. 4B) . Both mannose and mannan substantially inhibited Interestingly, the IFN-α production of DC by virus infection could be markedly inhibited with galactose and N-acetylgalacthe uptake of FITC-dextran (70 and 68% respectively) by Mo-DC compared to the minimal effect seen with galactose tosamine, sugars which do not influence MMR-mannose binding (39). Further, it appeared that a subset of blood DC (15%), indicating that Mo-DC employed a mannose-specific receptor (most likely to be MMR) to mediate FITC-dextran (ILT3 ϩ ILT1 ϩ ) expressed MMR at a low level (48) . However, our results established that blood DC do not express the uptake. In contrast, these sugars had little or no effect on FITC-dextran uptake by macrophages, indicating either MMR at both the mRNA and the protein levels (Figs 2 and  3 ). There may be differences in the blood DC preparations, pinocytosis or a receptor system with different specificity such as the lipoprotein-related protein (40) is the predominant however, and further investigation is required to clarify this possibility. This data also raises the possibility of an alternative mechanism for the uptake. The uptake by LC was slightly inhibited by galactose or mannose (20 and 25% respectively) receptor with specificity for carbohydrate ligands, perhaps DEC-205, being involved in antigen uptake by blood DC. and to a greater extent by the mannan (48%). This may indicate that LC utilize a receptor system with different ligand DEC-205 has been implicated as an antigen-uptake receptor because it is structurally similar to the MMR and DC specificity from that of mannose-specific receptors in addition to their high pinocytotic activity. After 48 h of in vitro culture incubated with a rabbit anti-mouse DEC-205 could elicit the proliferation of rabbit IgG specific T lymphocytes (20) . in media, LC uptake of FITC-dextran was reduced by Ͼ50% (data not shown). The small level of FITC-dextran uptake Recently, the antigen detected by mAb MR6 (gp200-MR6) was identified as DEC-205 (49) and the adjuvant effect of by both immature and activated blood DC was not affected by the presence of mannose or mannan (data not shown), mAb MR6 (50) also suggests that DEC-205 is involved in antigen uptake. MR6 was raised against human thymic stromal suggesting that mannose-specific receptors are not involved. cells and stains thymic cortical epithelium intensely with weak staining of T and B lymphocytes, macrophages, dendritic Discussion cells and some non-lymphoid tissues such as urothelium and mammary epithelium (51, 52) . Interestingly, expression of Two cell-surface multilectins, DEC-205 and MMR have been identified in various DC preparations (17, 25, 27, 41) . Both gp200-MR6 in breast carcinoma appeared to decrease with malignant progression (53) . These reports indicate that human molecules belong to the MMR family and are structurally similar. However, the overall amino acid identity between the DEC-205 is expressed broadly in lymphoid and non-lymphoid tissues as shown in mice using rabbit anti-mouse DEC-205 DEC-205 and the MMR is only 27% (20, 27) , suggesting that they have distinct functions, which may be related to their and NLDC-145 (the mAb against mouse DEC-205) (25, 26, 41) . Although MR6 behaved as either an agonist or antagonist for expression and ligand specificity. This study provides the first comparison of DEC-205 and MMR expression with FITC-IL-4 and this function was linked to IL-4 receptor, the ligand and function of DEC-205 is unknown. We asked whether DECdextran uptake by various populations of human DC.
Immature Mo-DC utilize the MMR as a high capacity and 205 was involved in carbohydrate-conjugated antigen uptake by assessing the expression of DEC-205 on potential antigenbroad specificity antigen-uptake receptor for FITC-dextran (17) or mannosylated antigens (18), and this results in 100-presenting cells and by correlating the FITC-dextran uptake in various preparations of DC. to 1000-fold more efficient presentation of mannosylated antigens than non-mannosylated antigens to T lymphocytes
The rabbit IgG anti-DEC-205 detected only a low level of DEC-205 in immature lin -HLA-DR low blood DC (Fig. 1A) . This (14, 21) . However, our data suggest that neither LC nor blood DC express the MMR. Mouse LC take up zymosan, and the blood DC population can be divided into a CD11c ϩ subset (myeloid DC) and a CD11c -subset (plasmacytoid DC) (48), uptake can be inhibited with mannan and β-glucan (12). This indicates that a mannan/β-glucan receptor exist in LC. It was thus it appears that both DC subsets expressed low levels of DEC-205. After overnight culture in the presence of FCS, the reported that human LC expressed the MMR detected by polyclonal anti-MMR (42) but mAb against MMR failed to lineage-negative blood DC split into a HLA-DR high subset and a HLA-DR low subset. Both subsets expressed similar levels detect MMR on LC (43, 44) . Furthermore, recent in situ studies using immunological and in situ hybridization methods of DEC-205 on their surface or showed minimal increase compared to immature blood DC. taking up 10-20 times more antigens in our system (Fig. 4) , 
